# Treatment With Namenda in Women at Risk for Cognitive Decline

> **NCT00242632** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 22 (actual)

## Conditions studied

- Dementia

## Interventions

- **DRUG:** Namenda

## Key facts

- **NCT ID:** NCT00242632
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242632, "Treatment With Namenda in Women at Risk for Cognitive Decline". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00242632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*